Artelo Biosciences, Inc. (ARTL)
5.27
-0.14
(-2.59%)
USD |
NASDAQ |
Apr 15, 16:00
5.29
+0.02
(+0.38%)
After-Hours: 20:00
Artelo Biosciences Research and Development Expense (Annual) : 5.423M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 93.26M |
| GlucoTrack, Inc. | 9.813M |
| Ovid Therapeutics, Inc. | 25.38M |
| Apellis Pharmaceuticals, Inc. | 295.85M |
| Gossamer Bio, Inc. | 174.07M |